Skip to main content
See every side of every news story
Published loading...Updated

Acuitas Therapeutics’ Scientists Collaborate with the University of Zurich and the University of Pennsylvania to Develop a Novel Deep Learning Model for Efficient Adenine Base Editing - Life Sciences British Columbia

Acuitas Therapeutics announced publication “Predicting adenine base editing efficiencies in different cellular contexts by deep learning."
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

lifesciencesbc.ca broke the news in on Tuesday, July 29, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal